Glenmark's current portfolio consists of 151 products authorised for distribution in the US.
Glenmark Pharmaceuticals on March 15 said it has received final approval from the US health regulator for its generic version of BenzaClin gel used in treatment of acne.
The approval granted to Glenmark Pharmaceuticals Inc, USA (Glenmark) by the United States Food & Drug Administration (USFDA) is for for Clindamycin and Benzoyl Peroxide Gel, 1 percent|5 percent, a generic version of BenzaClin1 Gel, 1 percent|5 percent, of Valeant Bermuda, the company said in a statement.
Citing IQVIATM sales data, Glenmark said BenzaClin Gel, 1 percent |5 per cent had sales of USD 99.4 million in the 12-month period ended January 2019.
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .